Evidence map›Paper›PMID 35381296›Full record

ArticleJournal of neuroradiology = Journal de neuroradiologie2022

Reversible neurological and brain MRI changes following COVID-19 vaccination: A case report.

Anuj Rastogi, Arina Bingeliene, Antonio P Strafella, David F Tang-Wai, Peter E Wu, Daniel M Mandell

Open access · greenAbstract readCase ReportsLetter
In one paragraph

Article in Journal of neuroradiology = Journal de neuroradiologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Post-COVID-19 Vaccination CNS Magnetic Resonance Imaging Findings: A Systematic Review.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Review
  7. COVID-19 vaccination-triggered cluster headache episodes with frequent attacks.Cephalalgia : an international journal of headache · 2022
    Article
  8. Neurologia (Barcelona, Spain) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Anuj RastogiDivision of Neurology, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: anuj.rastogi@uhn.ca.
Arina BingelieneDivision of Neurology, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Antonio P StrafellaDivision of Neurology, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada; Division of Brain, Imaging and Behaviour-Systems Neuroscience, Krembil Brain Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada; Morton and Gloria Shulman Movement Disorder Unit and E.J. Safra Parkinson Disease Program, Neurology Division, Department of Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
David F Tang-WaiDivision of Neurology, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada; University Health Network Autoimmune Encephalitis Clinic, Krembil Brain Institute, Toronto, Ontario, Canada.
Peter E WuDivision of Clinical Pharmacology and Toxicology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of General Internal Medicine and Geriatrics, University Health Network, Toronto, Ontario, Canada.
Daniel M MandellDivision of Neuroradiology, Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada.
University Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVarious neurological sequalae have been described following COVID-19 vaccination. Here we describe the first case of untreated post COVID-19 vaccine encephalitis with spontaneous resolution of contrast enhancing hyperintensities on MRI concomitant with clinical improvement. CASE PRESENTATION: A 59-year-old woman presented with a two-day history of unsteady gait, incoordination, visual symptoms, and lethargy. She had received AZD1222 (AstraZeneca) and mRNA-1273 (Moderna) COVID-19 vaccines at 3 months and 12 days, respectively, before presentation. Brain MRI showed no abnormality on the non-enhanced sequences, but numerous enhancing lesions in the cerebral cortex, deep grey matter, brainstem, and cerebellum. Treatment was expectant, the patient improved clinically over 10 days, and repeat MRI showed near complete resolution of the imaging abnormality.

conclusionsWe describe neurological deterioration 12 days after a second dose of COVID-19 vaccine. There was no evidence of edema or demyelinating lesions in the brain on MRI, but there was extensive contrast-enhancement indicating loss of blood-brain barrier (BBB) integrity. This provides a potential in vivo, clinical-imaging correlate of the post-mortem evidence that SARS-CoV-2 spike protein may induce loss of BBB permeability. While this adds to the list of rare adverse neurological reactions to COVID-19 vaccination, the benefits of receiving the vaccine far outweigh these risks.

Indexed as

COVID-19COVID-19 VaccinesBrainChAdOx1 nCoV-19FemaleHumansMagnetic Resonance ImagingMiddle AgedSARS-CoV-2Spike Glycoprotein, CoronavirusVaccinationChAdOx1 nCoV-19COVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID35381296
PMCPMC8976577
OpenAlexW4224291522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.